跳至主要内容
临床试验/CTRI/2024/07/071026
CTRI/2024/07/071026尚未招募Unknown

Effectiveness of Carbetocin versus Oxytocin in prevention of postpartum hemorrhage during Caesarean section in singleton pregnancy; Randomised clinical trial

Aishwarya H K1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年8月1日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
120
试验地点
1
主要终点
BLOOD LOSS

研究概览

简要总结

Postpartum hemorrhage remains the leading cause of maternal mortality in developing countries and a significant proportion of these cases are attributable to uterine atony. In contrast to the advances made in the treatment of postpartum hemorrhage, there has been few novel prophylactic agents. This study will be undertaken to analyze the Effectiveness of carbetocin compared to oxytocin for the prevention of postpartum hemorrhage in caesarean section in singleton pregnancy.

With this background, we will be conducting a study to compare the  Effectiveness of Carbetocin Versus Oxytocin in Prevention of Postpartum Hemorrhage During Caesarean Section in Singleton Pregnancy : Randomised Clinical Trial

This study will be a randomized single blinded, comparative study, to be carried out in 120 participants,  undergoing Caesarean section under spinal/general anesthesia/ CESA . The patients will be randomly divided into 2 groups of 60 each. Group A (n=60 ) will receive 100 mcg of Inj. Carbetocin . Group B (n=60 ) will receive 10 IU Inj. Oxytocin.

The blood pressure , amount of hemoglobin , need of additional uterotonics  , uterine tone , uterine position,  urine output, occurrence of adverse effects will be assessed and recorded. All the findings and observations made during the entire study will be tabulated, graphically depicted wherever possible, statistically analysed and inference will be drawn to evaluate and compare the  Effectiveness of Carbetocin Versus Oxytocin in Prevention of Postpartum Hemorrhage During Caesarean Section in Singleton Pregnancy.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • 1.Age: 18 to 45 years.
  • 2.Period of gestation ≥ 28weeks.
  • 3.Willing to participate in study.

排除标准

  • ➢ History of epilepsy and coagulation disorders ➢ Eclampsia, HELLP syndrome in present pregnancy ➢ History of classical uterine incision ➢ Patients with Cardiovascular, Renal, Hepatic disorders in present and past pregnancies ➢ Placenta previa ➢ Abruptio placentae ➢ Past h/o PPH.

结局指标

主要结局

BLOOD LOSS

时间窗: Intra operatively and at 24 hours from OT

次要结局

  • 1.BLOOD PRESSURE(2.UTERINE TONE)

研究者

发起方
Aishwarya H K
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Aishwarya H K

RIMS.

研究点 (1)

Loading locations...

相似试验